Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 1.00 |
| ▸ | PPARD | Q03181 | 6/20 | 1.00 |
| ▸ | PPARA | Q07869 | 6/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | FABP4 | P15090 | 4/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | NR4A2 | P43354 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | BLM | P54132 | 3/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | AKR1C3 | P42330 | 2/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | RECQL | P46063 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7875988 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| Arachidonic Acid SCHEMBL18185463 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| SCHEMBL7875990 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| SCHEMBL17540736 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| SCHEMBL542242 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| SCHEMBL13033028 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| Arachidonic Acid SCHEMBL25417373 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| Arachidonic Acid SCHEMBL18185503 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| Arachidonic Acid SCHEMBL20656587 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 | |
| Arachidonic Acid SCHEMBL3064936 | 1.00 | PPARG (1.00) | PPARGPPARDPPARAALDH1A1FABP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 507 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024168236-A2 | METHODS FOR DETECTING AND TREATING CAVERNOUS ANGIOMA | THE UNIVERSITY OF CHICAGO (US) | 2024-08-15 | — | — | WO | claimed |
| EP-3383380-B1 | LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE | BIOZEP AS (NO) | 2023-01-04 | — | — | EP | claimed |
| CN-114806022-A | Positively charged biological filler and preparation method thereof | 中国科学院青岛生物能源与过程研究所 | 2022-07-29 | — | — | CN | claimed |
| CN-112996500-A | Compositions and methods for modulating ELOVL2 | 优美佳生物技术有限公司 | 2021-06-18 | — | — | CN | claimed |
| US-20150209441-A1 | Anandamide-Modified Nucleic Acid Molecules | BASECLICK GMBH (DE) | 2015-07-30 | — | — | US | claimed |
| CN-104540525-A | Anandamide-modified nucleic acid molecules | BASECLICK GMBH | 2015-04-22 | — | — | CN | claimed |
| EP-1854462-A1 | Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids | DSMIP Assets B.V. (NL) | 2007-11-14 | — | — | EP | claimed |
| EP-1852115-A1 | Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids | DSM IP Assets B.V. (NL) | 2007-11-07 | — | — | EP | claimed |
| EP-1370257-B1 | COMPOSITION FOR THE PREVENTION OF OSTEOPOROSIS consisting of A COMBINATION OF ISOFLAVONES AND POLYUNSATURATED FATTY ACIDS | DSM IP ASSETS BV (NL) | 2007-07-25 | — | — | EP | claimed |
| JP-1019018-A | — | — | None | — | — | JP | disclosed |
| EP-4733373-A1 | METHOD FOR PRODUCING HIGHLY UNSATURATED FATTY ACID ESTER COMPOSITION | Nissui Corporation (JP) | 2026-04-29 | — | — | EP | disclosed |
| EP-3817810-B1 | MANUFACTURING PROCESS AND INTERMEDIATES FOR A PYRROLO[2,3- D]PYRIMIDINE COMPOUND AND USE THEREOF | PFIZER (US) | 2025-09-17 | — | — | EP | disclosed |
| US-20250282789-A1 | CRYSTALLINE PYRIMIDINYL-3,8-DIAZABICYCLO[3.2.1]OCTANYLMETHANONE COMPOUND AND USE THEREOF | PFIZER INC. (US) | 2025-09-11 | — | — | US | disclosed |
| US-12410172-B2 | Crystalline forms of 3-cyano-1-[4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl]cyclobutaneacetonitrile, and use thereof | PFIZER INC. (US) | 2025-09-09 | — | — | US | disclosed |
| EP-0749468-A1 | REFINING OIL COMPOSITIONS | NORSK HYDRO a.s. (NO) | 1996-12-27 | — | — | EP | disclosed |
| EP-0449436-B1 | Method of separating sesamin analogues | TAKEMOTO OIL & FAT CO LTD (JP) | 1996-08-14 | — | — | EP | disclosed |
| WO-1995024459-A1 | REFINING OIL COMPOSITIONS | NORSK HYDRO A.S (NO) | 1995-09-14 | — | — | WO | disclosed |
| US-5209826-A | Method of separating sesamin and episesamin | TAKEMOTO YUSHI KABUSHIKI KAISHA (JP) | 1993-05-11 | — | — | US | disclosed |
| EP-0449436-A1 | Method of separating sesamin analogues | Takemoto Yushi Kabushiki Kaisha (JP) | 1991-10-02 | — | — | EP | disclosed |
| JP-S6419018-A | CHOLESTEROL DEPRESSING AGENT | NIPPON OILS & FATS CO LTD | 1989-01-23 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282789-A1 | CRYSTALLINE PYRIMIDINYL-3,8-DIAZABICYCLO[3.2.1]OCTANYLMETHANONE COMPOUND AND USE THEREOF | PDXK, OR10J3, CYP2J2 | PPARG 643/4885PPARD 207/4885PPARA 240/4885 |
| US-12410172-B2 | Crystalline forms of 3-cyano-1-[4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl]cyclobutaneacetonitrile, and use thereof | CYP4B1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CALU | PPARG 1333/4885PPARD 831/4885PPARA 668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.